In 2015, global revenue generated by respiratory inhaler devices stood at USD 30 billion witnessing a compound annual growth rate of 4.3% over the forecast period i.e. 2016-2023. MDIs (metered dose inhalers) constituted the largest market share among inhalation systems followed by dry powder inhaler which is used for treating cystic fibrosis, a life threatening lung disease. In 2015, MDIs segment accounted for 70% of the global revenue.North America is anticipated to hold the largest consumer base of respiratory inhaler devices followed by Western Europe. North America and Western Europe collectively accounted 65% of the total respiratory inhaler device market in terms of revenue share by the end of 2015 owing to the increasing environmental pollution due to industrialization and smoking habits which is commonly found among youngsters.
Asia-Pacific is anticipated to be the most attractive market in terms of compound annual growth rate, Asia Pacific market is estimated to project a CAGR of 5% over the forecast period due to increasing prevalence of asthma and COPD among children and the geriatric population.
Get Full Table Of Content Respiratory Inhaler Device Market:
[url]http://www.researchnester.com/toc-request/1/rep-id-202 [/url]
sia-Pacific is anticipated to be the most attractive market in terms of compound annual growth rate, Asia Pacific market is estimated to project a CAGR of 5% over the forecast period due to increasing prevalence of asthma and COPD among children and the geriatric population.
Key Players
GlaxoSmithKline Plc
Novartis AG
Merck & Co. Inc.
AstraZeneca Plc
Philips Healthcare
3M Health Care
Allied Healthcare Products Inc.
Sunovion Pharmaceuticals Inc.
GF Healthcare Products
Smith Medicals
Lincare Holdings Inc.
Baxter International.
Scope and Context
Overview of the Parent Market
Analyst View
Segmentation
By Type Market Size & Y-O-Y Growth Analysis
By Application Market Size & Y-O-Y Growth Analysis
By Component Market Size & Y-O-Y Growth Analysis
Get Free Sample Report of Respiratory Inhaler Device Market:
[url]http://www.researchnester.com/sample-request/2/rep-id-202 [/url]
By Regions
Global Respiratory Inhaler Device Market has been studied on countries and regions like:
North America (U.S., Canada) Market Size & Y-O-Y Growth Analysis
Latin America (Mexico, Brazil, Rest of Latin America) Market Size & Y-O-Y Growth Analysis
Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size & Y-O-Y Growth Analysis
Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia) Market Size & Y-O-Y Growth Analysis
Middle East and North Africa (MENA) Market Size & Y-O-Y Growth Analysis
Rest of World Market Size & Y-O-Y Growth Analysis
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
For more information visit:[url] http://www.researchnester.com/reports/respiratory-inhaler-device-market-global-demand-analysis-opportunity-outlook-2023/202[/url]
contact us
Ajay Daniel
1820 Avenue M, Suite# 1113,
Brooklyn, New York 11230
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919
Email: ajay.daniel@researchnester.com
web:[url]www.researchnester.com[/url]